Drug profile · INN
riluzole
RILUTEK
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
riluzole (RILUTEK) is an FDA-listed pharmaceutical active ingredient. Associated with Aquestive Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN riluzole
Brand RILUTEK
Route ORAL
Formulation FILM
ATC code N07XX02
Originator Aquestive Therapeutics
Related patents
Search patents →Frequently asked questions
What is riluzole?
riluzole (RILUTEK) is an FDA-listed pharmaceutical active ingredient. Associated with Aquestive Therapeutics. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for riluzole?
RILUTEK is a marketed brand name for riluzole. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of riluzole?
riluzole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.